- NLM Classification (21)
- WG Cardiovascular system (117)
Abraha, I. and Chiarolla, E. and Corio, M. and Gillespie, F. and Migliore, A. and Cerbo, M. and Lauvrak, V. and Fagerlund, B.C. and Harboe, I. and Stoinska-Schneider, A. and Wild, C. (2019): Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk. HTA-Projektbericht 115.
Adlbrecht, C. and Radlberger, P. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Cardiac contractility modulation for heart failure. Systematic review]. Decision Support Document 15/Update2009.
Adlbrecht, C. and Radlberger, P. and Guba, B. and Felder-Puig, R. (2008): [Cardiac contractility modulation for heart failure. Systematic review]. Decision Support Document 15.
Adlbrecht, C. and Radlberger, P. and Reiner-Theisen, I. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Drug coated balloon catheter. Systematic Review. Decision Support Document 24.
Adlbrecht, C. and Radlberger, P. (2010): Cardiac contractility modulation for heart failure. Decision Support Document 15/Update 2010.
Chiarolla, E. and Orso, M. and Götz, G. and Stanak, M. and Wild, C. and Jefferson, T. (2019): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018. Decision Support Document 103/ Update 2018.
Emprechtinger, R. (2018): Echocardiography: Guideline recommendations and options to identify inappropriate use as well as usage rate in Austria. HTA-Projektbericht 98.
Erdos, J. (2022): Percutaneous transvascular implantation of a coronary sinus reducing stent. 1. Update 2022. Decision Support Document 121/ Update 2022.
Ettinger, S. and Stanak, M. and Huić, M. and Hacek, R.T. and Ercevic, D. and Grenkovic, R. and Wild, C. (2016): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk.. Decision Support Document 103.
Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.
Felder-Puig, R. (2007): [Hypertension and weight-loss. Treatment options]. HTA-Newsletter 54: pp. 2-3.
Felder-Puig, R. (2006): [Coronary surgery, specif. PTCA: Quality and frequencies]. HTA-Newsletter 52: pp. 3-4.
Fischer, S. and Tüchler, H. and Piso, B. (2016): Outpatient cardiac rehabilitation part VII: Economic Evaluation. HTA-Projektbericht 89.
Fischer, S. and Zechmeister-Koss, I. (2014): Costs of day surgery in Austria: An analysis of data and methods for varicose vein surgery as an example. HTA-Projektbericht 71.
Fleischner, B. (2009): Acquisition Processes of Certain Product Groups in Hospitals - Orthopaedic and Cardiac Implants. HTA Projektbericht 38.
Gartlehner, G. and Falkner, E. and Guba, B. and Felder-Puig, R. (2008): [Optical coherence tomography. Systematic review]. Decision Support Document 13.
Gassner, L. and Reinsperger, I. (2021): National strategies and programmes for preventing and managing non-communicable diseases in selected countries. HTA-Projektbericht 139.
Geiger-Gritsch, S. (2008): Stent-graft Implantation for diseases of the ascending aorta. HTA-Newsletter 68: p. 2.
Geiger-Gritsch, S. and Piso, B. and Guba, B. and Felder-Puig, R. (2008): [Stent-grafting of the ascending aorta. Systematic review]. Decision Support Document 14.
Geiger-Gritsch, S. (2010): Stent-grafting of the ascending aorta . Decision Support Document 14/Addendum 2010.
Goetz, G. and Walter, M. and Wohlhöfner, K. and Wittenberg, H. and Saal, S. and Stephan, K.M. and Dohle, C. (2021): Robotics and functional electrical stimulation for stroke rehabilitation. HTA-Projektbericht 128.
Goetz, G. and Wernly, B. (2022): Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022. Decision Support Document 103/ 2. Update 2022.
Goetz, G. and Schmidt, L. and Erdos, J. and Ciutan, M. and Florescu, S. and Sasu, C. and Scintee, S. G. (2019): POCT/ Point of Care Tests: D-Dimer and Troponin. HTA-Projektbericht 124.
Gottardi, R. and Wild, C. (2011): Percutaneous aortic valve replacement (with a side note on hybrid operating rooms). Decision Support Document 18/Update 2011.
Gyimesi, M. and Piso, B. and Tüchler, H. (2010): Outpatient cardiac rehabilitation. Part 3a: Retrospective cohort study (with/without phase III rehabilitation) - explorative analysis and developing of an evaluation plan. HTA-Projektbericht 31a.
Hawlik, K. and Winkler, R. (2018): Baroreceptor activation therapy for treatment-resistant hypertension. Decision Support Document 113.
Hintringer, K. and Warmuth, M. (2013): Percutaneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB). Update 2013. Decision Support Document 24/ Update 2013.
Huic, M. and Erdos, J. and Wild, C. (2024): Point of Care Tests (POCT): D-Dimer and Troponin. HTA-Projektbericht 124/ 1. Update.
Janatzek, S. and ThomasS, S. and Mad, P. (2010): Percutaneous Repair of mitral regurgitation with the MitraClip . Decision Support Document 41.
Jeindl, R. and Goetz, G. (2021): Percutaneous left ventricular assist devices: micro-axial flow pumps. Decision Support Document 124.
Jeindl, R. and Wernly, B. (2022): His-bundle-pacing for patients requiring a permanent pacemaker or cardiac resynchronisation. Decision Support Document 132.
Johansson, T. and Mathis, S. (2010): Laser angioplasty of coronary arteries . Decision Support Document 39.
Johansson, T. and Wild, C. (2009): Telemedicine in Stroke Management. Systematic Review. HTA-Projektbericht 029.
Kisser, A. and Emprechtinger, R. (2016): Leadless pacemakers for right ventricle pacing. Decision Support Document 97.
Kvas, E. (2006): [Drug eluting stents in comparison to uncoated stents in the treatment of cardiopathy]. Rapid Assessment LBI-HTA 01.
Langer, T. (2006): [Bypass materials in vascular surgery]. HTA-Newsletter 48: pp. 3-4.
Mad, P. (2007): [Telemonitoring for patients with chronic heart failure]. HTA-Newsletter 56: p. 4.
Mad, P. (2007): Drug Eluting Stents (DES): Safety aspects. HTA-Newsletter 53: pp. 2-3.
Mad, P. (2006): [Computed tomographic angiography for coronary artery evaluation]. HTA-Newsletter 48: p. 4.
Mad, P. and Falkner, E. and Guba, B. and Gartlehner, G. (2008): [Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction in patients with congenital heart defects. Systematic review]. Decision Support Document 10.
Mad, P. and Domanovits, H. and Fazelnia, C. and Stiassny, K. (2007): Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM: An International Journal of Medicine 100 (4): pp. 203-210.
Mathis, S. and Johansson, T. and Mad, P. and Mittermayr, T. (2011): Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety. Decision Support Document 46.
Nachtnebel, A. and Reinsperger, I. (2012): Percutaneous repair of mitral regurgitation with the MitraClip® . Decision Support Document 41 / Update 2012.
Nachtnebel, A. and Warmuth, M. (2013): Percutaneous coronary intervention for chronic total occlusion. Decision Support Document 64.
Patera, N. and Warmuth, M. (2011): Training therapy in physical medicine: Rapid systematic review. Decision Support Document 51.
Piso, B. (2008): Outpatient Cardiac Rehabilitation Part I- Evaluation and Indicators Part II- Comparative analysis of various rehabilitation models and Phase III. HTA-Projektbericht 15.
Piso, B. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Stent-grafting of the ascending aorta. Systematic review]. Decision Support Document 14/Update2009.
Piso, B. and Gyimesi, M. and Tüchler, H. (2010): Outpatient cardiac rehabilitation. Part 3b: Retrospective cohort study (with/without phase III rehabilitation) - application of the evaluation plan. HTA-Projektbericht 31b.
Piso, B. and Tüchler, H. (2016): Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III). HTA-Projektbericht 90.
Piso, B. and Tüchler, H. (2012): Outpatient cardiac rehabilitation. Part V: Study protocol "Multi-centre, prospective cohort study with two control groups (with/without phase III)". Decision Support Document 50.
Piso, B. and Tüchler, H. (2011): Outpatient cardiac rehabilitation part IV: Options for a prospective study. Decision Support Document 048.
Reichel, M. and Zechmeister-Koss, I. (2012): Renal denervation in patients with essential hypertension . Decision Support Document 45 / Update 2012.
Reinsperger, I. and Nachtnebel, A. (2014): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (1st Update 2014). Decision Support Document 44/ Update 2014.
Reinsperger, I. and Piso, B. (2015): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB) (1st Update 2015). Decision Support Document 68/ 1. Update 2015.
Reinsperger, I. and Piso, B. (2015): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (2nd Update 2015). Decision Support Document 44/ 2. Update 2015.
Robausch, M. and Emprechtinger, R. (2017): Percutaneous aortic valve replacement (TAVI) in Austria. Part 2: Data analysis. HTA-Projektbericht 95b.
Rothschedl, E. and Nachtnebel, A. (2015): Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease. Decision Support Document 84.
Schumacher, I. and Warmuth, M. (2011): Exercise therapy (Krankengymnastik/Heilgymnastik) in physical medicine: Rapid systematic review. Decision Support Document 52.
Scott, A. and Kern, J. and Vreugdenburg, T. (2024): Caval valve implantation (CAVI) for severe tricuspid regurgitation. Decision Support Document 139.
Semlitsch, T. and Krenn, C. (2024): Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) in patients with coronary artery disease (CAD). 3rd Update. Decision Support Document 24/ 3. Update 2024.
Semlitsch, T. and Loder, C. (2023): Percutaneous mitral valve repair with a clip device in patients with mitral regurgitation. 2nd Update 2023. Decision Support Document 41/ Update 2023.
Semlitsch, T. and Zipp, C. and Loder, C. (2022): Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022. Decision Support Document 64/ Update 2022.
Semlitsch, T. and Loder, C. (2020): Leadless pacemaker for right ventricle pacing (Update 2020). Decision Support Document 97/ Update 2020.
Semlitsch, T. and Ciutan, M. and Scintee, S.G. (2019): Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report. Decision Support Document 81/ Update 2019.
Semlitsch, T. and Horvath, K. (2016): Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016 . Decision Support Document 24/ 2. Update 2016.
Semlitsch, T. and Krenn, C. (2018): (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018. Decision Support Document 44/ Update 2018.
Semlitsch, T. and Posch, N. (2017): Leadless pacemakers for right ventricle pacing. Update 2017. Decision Support Document 97/ 1. Update 2017.
Stanak, M. and Rothschedl, E. (2020): Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent. Decision Support Document 121.
Stumpner, T. (2013): Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks. Decision Support Document 70.
Wagner, G. and Glechner, A. (2018): Subcutaneous implantable cardioverter defibrillator (ICD). Decision Support Document 109.
Walter, M. and Strohmaier, C. (2020): Genetic Testing in the Context of Familial Hypercholesterolaemia Management. HTA-Projektbericht 130.
Warmuth, M. (2013): Endovascular repair of aortic aneurysms. Decision Support Document 69.
Warmuth, M. and Schumacher, I. (2011): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation . Decision Support Document 44.
Warmuth, M. and Schumacher, I. and Maringer, B. (2011): Efficacy and safety of treatment options for varicose veins. HTA-Projektbericht 051.
Warmuth, M. and Stumpner, T. (2013): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB). Decision Support Document 68.
Warmuth, M. and Stumpner, T. (2012): Therapeutic hypothermia (TH). Decision Support Document 63.
Wegman, M. and Thomas, S. and Deuber, HJ. (2011): Renal denervation in patients with essential hypertonia. Decision Support Document 45.
Wild, C. (2007): [Drug Eluting Stents (DES). Update February 27th, 2007. HTA in hospitals]. HTA in hospitals. Vienna, 27.02.2007.
Wild, C. (2006): [Carotid stenting for carotid artery stenosis]. HTA-Newsletter 46: p. 4.
Wild, C. (2005): [Statins for acute coronary syndrome]. HTA-Newsletter 42: pp. 3-4.
Wild, C. (2005): [Coronary heart disease. Risk models]. HTA-Newsletter 36: p. 3.
Wild, C. (2005): [Screening for abdominal aortic aneurysm (AAA)]. HTA-Newsletter 36: p. 2.
Wild, C. (2005): [Intraoperative ablation for atrial fibrillation]. HTA-Newsletter 33: p. 2.
Wild, C. (2004): [Drug eluting stents: An economic analysis]. HTA-Newsletter 31: pp. 3-4.
Wild, C. (2004): [Implantable defibrillators/ICD]. HTA-Newsletter 31: p. 2.
Wild, C. (2004): [Sclerotherapy for leg varicose veins]. HTA-Newsletter 30: pp. 2-3.
Wild, C. (2003): [Cardiac resynchronisation therapy (CRT) for heart failure]. HTA-Newsletter 23: pp. 3-4.
Wild, C. (2003): [Graftskin (Apligraf®) in the treatment of venous leg ulcers]. HTA-Newsletter 21: pp. 3-4.
Wild, C. (2003): [Computed tomography in screening for lung cancer]. HTA-Newsletter 21: p. 4.
Wild, C. (2003): [Troponin testing in acute coronary syndromes]. HTA-Newsletter 18: p. 4.
Wild, C. (2003): [Endovascular surgery for abdominal aortic aneurysm/AAA]. HTA-Newsletter 15: p. 4.
Wild, C. (2003): [Implantable cardioverter defibrillator]. HTA-Newsletter 14: p. 4.
Wild, C. (2002): [Glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes]. HTA-Newsletter 13: pp. 2-3.
Wild, C. (2002): [Coated stents]. HTA-Newsletter 13: pp. 3-4.
Wild, C. (2002): [Treatment of varicose veins]. HTA-Newsletter 12: pp. 3-4.
Wild, C. (2002): [Clopidogrel (Plavix): Secondary prevention of coronary heart disease]. HTA-Newsletter 04: p. 2.
Wild, C. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18/Update2009.
Wild, C. and Langley, T. and Guba, B. and Gartlehner, G. (2008): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18.
Wild, C. (2015): Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment. Decision Support Document 93.
Wild, C. (2013): Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) . Decision Support Document 71.
Wild, C. (2010): Percutaneous aortic valve replacement. Decision Support Document 18/Update 2010.
Wild, C. (2007): [Drug eluting stents. Status quo]. ÖKZ: Österreichische Krankenhauszeitung 48 (03).
Wild, C. and Frank, W. and Huber, K. and Konta, B. (2003): [GP IIb/IIIA inhibitors in the treatment of patients with coronary heart disease]. Köln: DIMDI. ISBN 3-89906-703-7.
Winkler, R. and Wild, C. (2020): Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure. Decision Support Document 119.
Winkler, R. (2015): Transcatheter mitral valve-in-valve implantation. Decision Support Document 82.
Wolf, S. (2022): Long COVID care pathways and structures: an updated scoping review. HTA-Projektbericht 135b/ Update.
Wolf, S. and Erdos, J (2021): Epidemiology of long COVID: a preliminary report. German short version of the original KCE report. HTA-Projektbericht 135a.
Wolf, S. and Erdos, J. (2021): Long COVID care pathways: a systematic review. HTA-Projektbericht 135b.
Wolf, S. and Goetz, G. (2022): Subcutaneous implantable cardioverter-defibrillator (S-ICD). 1. Update 2022: Systematic review. Decision Support Document 109/ Update 2022.
Wolf, S. and Fischer, S. (2017): Transcatheter Aortic Valve Implantation Part I: A systematic review of health economic evaluations. HTA-Projektbericht 95a.
Zechmeister, I. (2006): [Statins: Economic evaluation]. HTA-Newsletter 48: p. 2.
Zechmeister, I. and Stollenwerk, B. and Ara, R. and Ward, S. (2008): Statins for the Secondary Prevention of Cardiovascular Diseases: An Analysis of Expected Population Health Gains and Cost-Utility in Austria (Part II of the project 'Statins: A comparison between predicted and actual effects on population health in Austria') . HTA-Projektbericht 018.
Zechmeister, I. and Stollenwerk, B. and Langley, T. (2008): Have Statins Met Our Expectations? A Comparison of Expected Health Gains from Statins with Epidemiological Trends in Austria (Part III of the Project 'Statins: A Comparison Between Predicted and Actual Effects on Population Health in Austria'). HTA-Projektbericht 019.
Zechmeister, I. and Wild, C. (2006): [Statins and their prognosed as well as real impact on hospital services in Austria]. ITA-Projektbericht 30.
Zechmeister, I. (2006): [Cost-effectiveness of statins]. ITA-Newsletter March 2006: p. 3.
Zechmeister-Koss, I and Fischer, S. (2014): Drug eluting stents for the treatment of peripheral artery disease. Decision Support Document 75.
Zechmeister-Koss, I. and Rothschedl, E. (2015): Fully bioresorbable scaffolds for coronary artery disease. Decision Support Document 81.